Meredith Tremblay is a seasoned professional with extensive expertise in clinical quality assurance and compliance, currently serving as Senior Director of GCP Quality Management at Morphic Therapeutic since July 2023. Prior experience includes leadership roles at Alexion Pharmaceuticals, where responsibilities encompassed overseeing global clinical quality assurance across numerous developmental programs and trials, as well as enhancing inspection readiness and compliance in the Neurology therapeutic area. Meredith has held senior positions at Apellis Pharmaceuticals and TAKEDA PHARMACEUTICALS AMERICA, INC., focusing on clinical quality assurance and compliance management. Earlier career roles include significant contributions to R&D Quality Assurance at Shire and Sanofi Genzyme, bolstering regulatory compliance and audit execution. Meredith holds a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor of Science in Behavioral Neuroscience, along with completion of the Emerging Leaders Program at UMass Boston.
This person is not in any teams
This person is not in any offices